http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy debutripathy Blog en-us Sun, 21 Mar 2010 14:18:41 -0600 Fri, 05 Mar 2010 12:19:00 -0600 BlogCFC http://blogs.law.harvard.edu/tech/rss moderator@curetoday.com (moderator) moderator@curetoday.com (moderator) moderator@curetoday.com http://www.curetoday.com/assets/images/placeholder.gif http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy no http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2010/3/5/Health-care-reform--Is-there-a-Top-10-list With all the political debate and drama regarding health care reform, the forgotten party, of course, is the general public - the consumer of health care. With a massive bill still in play, there appears to be an "all or nothing" mentality. Perhaps t... News General Fri, 05 Mar 2010 12:19:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2010/3/5/Health-care-reform--Is-there-a-Top-10-list http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2010/2/19/Aspirin--The-Drug-of-the-Day A recent article showing that users of aspirin had a better survival rate after they were diagnosed with breast cancer received a lot of press, but what does it really mean? I think that this is an example of a very preliminary observation that ... News Fri, 19 Feb 2010 12:42:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2010/2/19/Aspirin--The-Drug-of-the-Day http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2010/2/2/Quality-Assurance-How-can-you-make-sure-you-are-not-a-victim-of-error I read with interest a recent article in The New York Times that exposed examples of errors in the administration of radiation therapy to patients at numerous facilities (As Technology Surges, Radiation Safeguards Lag). The stories on an individual l... Treatment Tue, 02 Feb 2010 07:53:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2010/2/2/Quality-Assurance-How-can-you-make-sure-you-are-not-a-victim-of-error http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/12/14/San-Antonio-Breast-Cancer-Symposium-What-have-we-learned-and-where-are-we-going Any high-impact scientific meeting will end with a sense of new direction, priorities for research, and expectations for clinically meaningful advances in the coming years. Based on presentations over the last few days, we may see new candidate risk ... News General Treatment Mon, 14 Dec 2009 09:02:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/12/14/San-Antonio-Breast-Cancer-Symposium-What-have-we-learned-and-where-are-we-going http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/12/13/Updates-on-treatment-for-HER2positive-breast-cancer In this morning's session, two updated results were presented on HER2-positive breast cancer. The first one was a trial that compared the HER2 kinase inhibitor, Tykerb, alone or in combination with Herceptin in patients who had already progressed... News General Treatment Sun, 13 Dec 2009 11:34:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/12/13/Updates-on-treatment-for-HER2positive-breast-cancer http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/12/11/The-importance-of-cellular-pathways-and-updates-on-antiangiogenic-drugs Today's morning session started off with a heavy dose of basic science--two important pathways were discussed. One is a key driver of cell growth that originates from growth factor receptors and is transmitted through an enzyme called PI3 kinase. Thi... News General Treatment Fri, 11 Dec 2009 16:47:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/12/11/The-importance-of-cellular-pathways-and-updates-on-antiangiogenic-drugs http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/12/11/Bisphosphonates-and-breast-cancer-risk Breast cancer prevention can be accomplished with tamoxifen, and this cuts the risk by about one-third to one-half, but very few women actually choose to go this route--in part, due to side effects. Dietary prevention studies have been negative as we... News General Treatment Fri, 11 Dec 2009 09:00:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/12/11/Bisphosphonates-and-breast-cancer-risk http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/12/10/New-insights-on-hormonal-therapies The theme of this morning's SABCS session was adjuvant hormonal therapy--an important topic given the fact that 70 percent of all women with early stage breast cancer receive this. Aromatase inhibitors (AIs) have become the preferred type of hormonal... News General Treatment Thu, 10 Dec 2009 17:19:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/12/10/New-insights-on-hormonal-therapies http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/12/9/What-to-expect-in-2009-at-SABCS The 32nd San Antonio Breast Cancer Symposium has a slightly different flavor this year--more definitive trial data that will influence how we take care of breast cancer. Last year happened to be a time when few major trials with immediate implication... News General Wed, 09 Dec 2009 18:08:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/12/9/What-to-expect-in-2009-at-SABCS http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/11/23/Mammographic-Screening--More-Heat-than-Light The saga of the new breast cancer screening guidelines issued by the US Health Preventive Services Task Force continues to evolve and has now polarized the public as well as professional fields. Many radiologists and surgeons, along with their patie... Diagnosis News Mon, 23 Nov 2009 10:06:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/11/23/Mammographic-Screening--More-Heat-than-Light http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/10/28/A-general-pullback-on-cancer-screening A very interesting turn of events occurred this past week in the world of cancer prevention. It was not so much a major discovery or new drug trial result, but rather a political and communication phenomenon. It happened on a couple of fronts. No... News Wed, 28 Oct 2009 07:50:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/10/28/A-general-pullback-on-cancer-screening http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/10/14/A-report-from-the-2009-ASCO-Breast-Cancer-Symposium The Breast Cancer Symposium, organized by ASCO (American Society of Clinical Oncology) along with several organizations dedicated to breast cancer care and research, held its 3rd annual meeting on October 8-10, 2009. This meeting focuses on translati... Treatment Wed, 14 Oct 2009 14:24:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/10/14/A-report-from-the-2009-ASCO-Breast-Cancer-Symposium http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/10/2/Survivorship-care-plans We have received several comments about the new trend and recommended practice of survivorship plans for patients following cancer treatment. By way of background, there has been a widening recognition that cancer patients are lost in the shuffle aft... Survivorship General Fri, 02 Oct 2009 12:08:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/10/2/Survivorship-care-plans http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/9/18/What-do-we-look-for-in-new-drugs Amid all the hoopla about a new drug approval, we sometimes lose sight of what we are actually gaining. Words like "significant improvement," "benefit," and "new treatment option" all sound like important milestones and lead to the logical conclusion... General Fri, 18 Sep 2009 08:12:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/9/18/What-do-we-look-for-in-new-drugs http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex//debutripathy/2009/9/1/Rationing-Health-Care-More-Heat-than-Light It is hard to avoid blogging about health care reform in the world of cancer at the present moment. It is a bright flashing light on our radar screen. Cancer care is so complex and typically a long-term process, so it will obviously be affected b... General Tue, 01 Sep 2009 10:48:00 -0600 http://www.curetoday.com/index.cfm/fuseaction/blog.showIndex/debutripathy/2009/9/1/Rationing-Health-Care-More-Heat-than-Light